Thomas Wyatt Nigeria Plc (NGX:THOMASWY)
Nigeria · Delayed Price · Currency is NGN 3.190
0.00 (0.00%)
At close: Aug 1, 2025
Verve Therapeutics Income Statement
Financials in millions NGN. Fiscal year is April - March.
Millions NGN. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2016 - 2020 |
| 71.61 | 80.28 | 87.15 | 71.39 | 56.33 | 76.97 | Upgrade | |
Revenue Growth (YoY) | -30.49% | -7.89% | 22.07% | 26.74% | -26.82% | 32.34% | Upgrade |
Cost of Revenue | 84.19 | 80.62 | 94.36 | 78.32 | 61.61 | 84.62 | Upgrade |
Gross Profit | -12.58 | -0.34 | -7.21 | -6.93 | -5.28 | -7.65 | Upgrade |
Selling, General & Admin | 54.3 | 67.08 | 52.62 | 54.24 | 58.55 | 44.57 | Upgrade |
Other Operating Expenses | -40.76 | -78.23 | -111.91 | -47.28 | -0.2 | -0.67 | Upgrade |
Operating Expenses | 22.47 | -2.22 | -50.77 | 6.96 | 58.35 | 43.9 | Upgrade |
Operating Income | -35.05 | 1.88 | 43.56 | -13.89 | -63.64 | -51.55 | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | -0 | - | - | Upgrade |
EBT Excluding Unusual Items | -35.05 | 1.88 | 43.56 | -13.89 | -63.64 | -51.55 | Upgrade |
Gain (Loss) on Sale of Assets | 3.25 | 3.25 | - | 101.43 | - | - | Upgrade |
Legal Settlements | - | - | - | - | 80.42 | - | Upgrade |
Other Unusual Items | - | - | - | 5 | - | - | Upgrade |
Pretax Income | -31.8 | 5.13 | 43.56 | 92.54 | 16.78 | -51.55 | Upgrade |
Income Tax Expense | 17.54 | 17.59 | 0.44 | 10.5 | 0.28 | 0.38 | Upgrade |
Earnings From Continuing Operations | -49.35 | -12.46 | 43.12 | 82.04 | 16.5 | -51.94 | Upgrade |
Minority Interest in Earnings | -22.19 | -27.72 | -6.37 | -7.7 | - | - | Upgrade |
Net Income | -71.53 | -40.18 | 36.75 | 74.34 | 16.5 | -51.94 | Upgrade |
Net Income to Common | -71.53 | -40.18 | 36.75 | 74.34 | 16.5 | -51.94 | Upgrade |
Net Income Growth | - | - | -50.57% | 350.63% | - | - | Upgrade |
Shares Outstanding (Basic) | 220 | 396 | 396 | 394 | 424 | 390 | Upgrade |
Shares Outstanding (Diluted) | 220 | 396 | 396 | 394 | 424 | 390 | Upgrade |
Shares Change (YoY) | - | - | 0.62% | -7.20% | 8.85% | -1.61% | Upgrade |
EPS (Basic) | -0.33 | -0.10 | 0.09 | 0.19 | 0.04 | -0.13 | Upgrade |
EPS (Diluted) | -0.33 | -0.10 | 0.09 | 0.19 | 0.04 | -0.13 | Upgrade |
EPS Growth | - | - | -50.88% | 385.60% | - | - | Upgrade |
Free Cash Flow | - | -5.72 | -20.59 | -36.82 | 41.6 | -1.53 | Upgrade |
Free Cash Flow Per Share | - | -0.01 | -0.05 | -0.09 | 0.10 | -0.00 | Upgrade |
Gross Margin | -17.57% | -0.43% | -8.27% | -9.71% | -9.38% | -9.94% | Upgrade |
Operating Margin | -48.95% | 2.34% | 49.98% | -19.45% | -112.97% | -66.97% | Upgrade |
Profit Margin | -99.89% | -50.05% | 42.16% | 104.13% | 29.29% | -67.47% | Upgrade |
Free Cash Flow Margin | - | -7.13% | -23.62% | -51.57% | 73.84% | -1.98% | Upgrade |
EBITDA | -27.81 | 23.94 | 64.72 | 4.85 | -46.02 | -33.96 | Upgrade |
EBITDA Margin | -38.83% | 29.82% | 74.26% | 6.79% | -81.69% | -44.12% | Upgrade |
D&A For EBITDA | 7.25 | 22.06 | 21.17 | 18.74 | 17.62 | 17.6 | Upgrade |
EBIT | -35.05 | 1.88 | 43.56 | -13.89 | -63.64 | -51.55 | Upgrade |
EBIT Margin | -48.95% | 2.34% | 49.98% | -19.45% | -112.97% | -66.97% | Upgrade |
Effective Tax Rate | - | 342.79% | 1.00% | 11.35% | 1.68% | - | Upgrade |
Advertising Expenses | - | 0.05 | 0.02 | 0.34 | 0.08 | - | Upgrade |
Updated May 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.